Carroll Financial Associates’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$290K Sell
7,436
-1,744
-19% -$65.7K 0.02% 329
2021
Q3
$316K Sell
9,180
-119
-1% -$4.07K 0.02% 311
2021
Q2
$293K Sell
9,299
-361
-4% -$11.6K 0.02% 337
2021
Q1
$301K Buy
9,660
+107
+1% +$3.21K 0.02% 316
2020
Q4
$287K Buy
9,553
+537
+6% +$15.8K 0.02% 305
2020
Q3
$229K Sell
9,016
-2,121
-19% -$56.2K 0.02% 316
2020
Q2
$288K Buy
11,137
+2,881
+35% +$76.5K 0.02% 282
2020
Q1
$216K Sell
8,256
-1,537
-16% -$48.3K 0.02% 291
2019
Q4
$318K Sell
9,793
-986
-9% -$31.9K 0.03% 272
2019
Q3
$371K Buy
10,779
+124
+1% +$4.16K 0.03% 257
2019
Q2
$364K Buy
10,655
+1,305
+14% +$46.1K 0.03% 250
2019
Q1
$334K Buy
9,350
+2,930
+46% +$99.8K 0.03% 244
2018
Q4
$204K Sell
6,420
-350
-5% -$11.2K 0.02% 265
2018
Q3
$210K Buy
6,770
+4,438
+190% +$137K 0.02% 275
2018
Q2
$70K Hold
2,332
0.01% 447
2018
Q1
$64K Sell
2,332
-99
-4% -$2.67K 0.01% 447
2017
Q4
$68K Hold
2,431
0.01% 434
2017
Q3
$66K Sell
2,431
-280
-10% -$7.49K 0.01% 438
2017
Q2
$69K Sell
2,711
-436
-14% -$11.1K 0.01% 433
2017
Q1
$80K Buy
3,147
+224
+8% +$5.71K 0.01% 396
2016
Q4
$73K Hold
2,923
0.01% 400
2016
Q3
$69K Sell
2,923
-4
-0.1% -$100 0.01% 410
2016
Q2
$75K Sell
2,927
-204
-7% -$5.05K 0.01% 379
2016
Q1
$80K Buy
3,131
+2,307
+280% +$51.7K 0.01% 349
2015
Q4
$16K Hold
824
﹤0.01% 636
2015
Q3
$17K Buy
824
+187
+29% +$4.2K ﹤0.01% 598
2015
Q2
$14K Buy
637
+351
+123% +$8.41K ﹤0.01% 634
2015
Q1
$7K Buy
286
+70
+32% +$1.73K ﹤0.01% 575
2014
Q4
$6K Sell
216
-485
-69% -$12.4K ﹤0.01% 546
2014
Q3
$18K Sell
701
-421
-38% -$9.86K 0.01% 472
2014
Q2
$29K Sell
1,122
-4,626
-80% -$118K 0.01% 403
2014
Q1
$138K Buy
5,748
+140
+2% +$2.95K 0.05% 182
2013
Q4
$109K Sell
5,608
-4,031
-42% -$81.1K 0.04% 200
2013
Q3
$203K Sell
9,639
-2,243
-19% -$49.1K 0.08% 142
2013
Q2
$261K Buy
+11,882
New +$288K 0.13% 103

Other funds holding EXC

Carroll Financial Associates's EXC Position: Q4 2021 in Review

Carroll Financial Associates reduced its Exelon (EXC) stake by 19% in Q4 2021, selling an estimated $65.7K and leaving 7,436 shares worth $290K. The position accounts for 0.02% of the portfolio, ranked #329.

Carroll Financial Associates first reported a position in EXC in Q2 2013 and has held it in 35 quarters since. The position peaked at $371K in Q3 2019. 1,069 funds tracked by Wall St. Rank hold EXC as of Q4 2021.

  • Carroll Financial Associates held 7,436 shares of Exelon worth $290K as of Q4 2021.
  • Carroll Financial Associates sold 1,744 Exelon shares in Q4 2021, an estimated $65.7K.
  • Exelon made up 0.02% of Carroll Financial Associates's portfolio in Q4 2021, its #329 holding.
  • Carroll Financial Associates first reported a position in Exelon in Q2 2013 and has held it in 35 quarters since.
  • Carroll Financial Associates's Exelon position peaked at $371K in Q3 2019.
  • 1,069 funds tracked by Wall St. Rank held Exelon as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.